Advancing Science Together
Research, manufacturing and global scientific partnerships
Scientific progress is rarely achieved alone.
Longevity Life Sciences brings together researchers, biotechnology companies, ingredient developers, formulation specialists, manufacturers and health organisations with a shared commitment to scientific integrity and responsible innovation.
University of Sydney
One of Australia’s leading research institutions, collaborating with Longevity Life Sciences to generate clinical evidence and advance the scientific understanding of cellular health.
SyncoZymes
A global biotechnology company specialising in advanced enzymatic biotechnology and coenzyme-related technologies.
SyncoZymes is the manufacturing partner behind CellVive NMN®, supporting the scientific, quality and regulatory program that enabled its use within Australian Listed Medicines.
Our collaboration is extending into the next generation of cellular-health ingredients and biotechnology.
Pharmako Biotechnologies
An Australian biotechnology company specialising in advanced formulation and delivery technologies.
Pharmako developed PlexoZome®, the liposomal delivery technology used within CellVive NMN® Advance.
Together, Longevity Life Sciences and Pharmako are exploring how advanced formulation can support the next generation of cellular-health products.
Mitsubishi Gas Chemical Company, Inc.
A global leader in specialty chemicals and life sciences innovation.
Longevity Life Sciences is collaborating with Mitsubishi Gas Chemical to bring clinically researched ingredients, including BioPQQ® and Spermidine, into the Australian market and support continued innovation across cellular health.
Work with us
We partner with organisations seeking to develop high-quality, evidence-led cellular-health products within regulated markets.
Our capabilities span scientific strategy, ingredient innovation, regulatory translation, clinical research, advanced formulation, manufacturing partnerships, commercialisation and market access.